HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 29 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,690,000 | -53.6% | 5,113,958 | +1.1% | 0.05% | -52.7% |
Q2 2020 | $3,643,000 | +121.5% | 5,060,160 | 0.0% | 0.11% | +77.4% |
Q1 2020 | $1,645,000 | -53.1% | 5,060,160 | +1.2% | 0.06% | -42.6% |
Q4 2019 | $3,510,000 | +5.6% | 5,000,000 | 0.0% | 0.11% | -12.2% |
Q3 2019 | $3,323,000 | – | 5,000,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 2,426,300 | $802,000 | 0.74% |
Cowen Prime Services LLC | 1,411,500 | $466,000 | 0.23% |
GSA CAPITAL PARTNERS LLP | 1,205,873 | $398,000 | 0.07% |
Nantahala Capital Management | 5,113,958 | $1,690,000 | 0.05% |
HighMark Wealth Management LLC | 80,000 | $26,000 | 0.02% |
Kalos Management, Inc. | 72,858 | $24,000 | 0.01% |
Qube Research & Technologies Ltd | 585,187 | $193,000 | 0.00% |
WINTON GROUP Ltd | 190,146 | $63,000 | 0.00% |
Ironwood Financial, llc | 1,571 | $1,000 | 0.00% |
Virtu Financial LLC | 12,049 | $4,000 | 0.00% |